Trial · NCT03743064
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Body Weight Over 12 Weeks | 100 mg Anamorelin HCl | 1.822 | Standard Error 0.263 | kg | |
| Mean Change From Baseline in Body Weight Over 12 Weeks | Placebo | 0.538 | Standard Error 0.250 | kg | |
| Mean Change From Baseline in 5-item Anorexia Symptom Subscale (5-IASS) Over 12 Weeks | 100 mg Anamorelin HCl | 3.432 | Standard Error 0.360 | score on a scale | |
| Mean Change From Baseline in 5-item Anorexia Symptom Subscale (5-IASS) Over 12 Weeks | Placebo | 3.291 | Standard Error 0.342 | score on a scale | |
| Duration in Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥0 kg) | 100 mg Anamorelin HCl | 8.859 | Standard Error 0.525 | weeks | |
| Duration in Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥0 kg) | Placebo | 6.778 | Standard Error 0.496 | weeks | |
| Duration in Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥1.5 kg) | 100 mg Anamorelin HCl | 5.490 | Standard Error 0.431 | weeks | |
| Duration in Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥1.5 kg) | Placebo | 3.087 | Standard Error 0.409 | weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥0 Points) | 100 mg Anamorelin HCl | 9.470 | Standard Error 0.392 | weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥0 Points) | Placebo | 8.842 | Standard Error 0.370 | weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥3 Points) | 100 mg Anamorelin HCl | 5.143 | Standard Error 0.410 | weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥3 Points) | Placebo | 4.992 | Standard Error 0.387 | weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03743064/results